Translating Metastatic Insights to Early-Stage Management: Current Practices and Future Direction

, , ,

Peer Exchange | <b>Latest Advances in ALK-Positive and BRAF-Positive V600E NSCLC: Efficacy Updates, Brain Metastases Management, and Optimal Treatment Sequencing </b>

Panelists discuss how the field aims to translate lessons learned from metastatic treatment into earlier-stage interventions for select patients, sharing their current practices and hopes for future advancements in care.

  1. How are we going to address this as a field as to moving what we have learned from the metastatic space to earlier stages for the small subset of patients? What do you do in your practice and what do you hope for in the future?